Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Shoenfeld Y, Aron-Maor A
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local citing links have been materialized yet.
Vaccine-induced autoimmunity
10.1006/jaut.1996.0091 · 1996
Adverse events associated with childhood vaccines other than pertussis and rubella
10.1001/jama.1994.03510440062034 · 1994
The Guillain–Barre syndrome
10.1056/nejm199204233261706 · 1992
Pathogenesis of immune-mediated neuropathies
10.1203/00006450-199333011-00016 · 1993
Antibodies in sera from patients wih inflammatory demyelinating polyradiculoneuropathy reactive with ganglioside LM1 and sulfatide of peripheral nerve myelin
10.1007/bf00315684 · 1991
Role of infection in the Guillain–Barre syndrome
10.1136/jnnp.27.5.395 · 1964
A theory of virus-induced demyelination in the Landry–Guillain–Barre syndrome
10.1007/bf00313775 · 1982
Role of infection in Guillain–Barre syndrome: laboratory confirmation of herpes virus in 41 cases
10.1002/ana.410090709 · 1981
Anti-neuroblastoma cell-line antibodies in inflammatory demyelinating polyneuropathy: inhibition in vitro by intravenous immunoglobulins
10.1212/wnl.38.10.1592 · 1988
Cytomegalovirus as a frequent cause of Guillain–Barre syndrome
10.1002/jmv.1890010105 · 1977
Guillain–Barre syndrome following administration of live measles vaccine
10.1016/0002-9343(76)90762-2 · 1976
Serologic evidence of Campylobacter Jejuni and E. coli enteritis in patients with Guillain–Barre syndrome
10.1001/archneur.1991.00530220102027 · 1991
Myelin- and microbe-specific antibodies in Guillian–Barre syndrome
10.1002/jcla.1860090506 · 1995
Unresolved referenced work
1993
Humoral mechanisms in imune neuropathies
10.1016/s0733-8619(18)30201-9 · 1992
Influenza vaccination and the Guillain–Barre syndrome
10.1056/nejm199812173392509 · 1998
The Guillain–Barre syndrome and the 1992–1993 and 1993–1994 influenza vaccines
10.1056/nejm199812173392501 · 1998
An epidemiologic and clinical evaluation of Guillain–Barre syndrome reported in association with the administration of swine influenza vaccines
10.1093/oxfordjournals.aje.a113809 · 1984
Immunization and risk of relapse of Guillain–Barre syndrome or chronic inflammatory demyelinating polyradiculoneuropathy
1996
Identification of autoanibodies associated with myelin damage in multiple sclerosis
10.1038/5532 · 1999
A shadow falls on Hepatitis B vaccination effort
10.1126/science.281.5377.630 · 1998
Central nervous system demyelination after immunization with recombinant Hepatitis B vaccine
10.1016/0140-6736(91)92034-y · 1991
Multiple sclerosis and Hepatitis B vaccination
10.1093/clinids/17.5.928-b · 1993
Is multiple sclerosis an age-dependent host response to measles?
10.1016/s0140-6736(76)91478-1 · 1976
Measles vaccination has had no effect on the occurrence of multiple sclerosis
10.1001/archneur.1996.00550120018007 · 1996
The role of infection and vaccination in the genesis of optic neuritis and multiple sclerosis in children
10.1111/j.1600-0404.1989.tb03904.x · 1989
Optic neuritis after influenza vaccination
10.1016/s0002-9394(14)70918-3 · 1997
Abnormal immune response to brain tissue antigen in the syndrome of autism
1982
Antibodies to myelin basic protein in children with autistic behaviour
10.1006/brbi.1993.1010 · 1993
Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism
10.1006/clin.1998.4588 · 1998
Autism, inflammatory bowel disease and MMR vaccine
10.1016/s0140-6736(98)26012-0 · 1998
Brief report: Dysregulated immune system in children with autism: beneficial effects of intravenous immunoglobulins on autistic characteristics
10.1007/bf02172828 · 1996
No evidence for measles, mumps and rubella vaccine-associated inflammatory bowel disease or autism in a 14 year prospective study
10.1016/s0140-6736(98)24018-9 · 1998
Autism and measles, mumps and rubella vaccine: no epidemiological evidence for a causal association
10.1016/s0140-6736(99)01239-8 · 1999
Sensorineural hearing loss following live measles vaccination
1998
Reports of sensorineural hearing loss after measles, mumps and rubella immunization
10.1136/adc.69.1.153 · 1993
Sudden sensory-neural hearing loss in patients with systemic lups erythematosus or lupus-like syndrome and antiphospholipid antibodies
1998
Neurological manifestations of antiphospholipid antibody syndrome
10.1177/096120339800700216 · 1998
Sudden sensoryneural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies
1998
Gait disturbances after measles, mumps and rubella vaccine
10.1016/s0140-6736(95)90302-x · 1995
Proteinuria and structural alterations in rat glomerular basement membranes induced by intravenously injected anti-laminin immunoglobulin G
10.1084/jem.156.1.128 · doi-reference
Vaccine-induced autoimmunity in the dog
10.1016/s0065-3519(99)80056-1 · doi-reference
Possible cause found for lyme arthritis
10.1126/science.281.5377.631 · doi-reference
Influenza vaccination in patients with rheumatic diseases. Safety and efficacy
10.1001/jama.1979.03300010037025 · doi-reference
Influenza vaccination of patients with systemic lupus erythematosus
10.7326/0003-4819-88-6-786 · doi-reference
Influenza immunization in systemic lupus erythematosus. A double-blind trial
10.7326/0003-4819-88-6-729 · doi-reference
Influenzal vaccine response in systemic lupus erythematosus
10.7326/0003-4819-88-6-735 · doi-reference
A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis
10.1212/wnl.48.2.312 · doi-reference
Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination
10.1007/bf00936886 · doi-reference
Influenza vaccination in patients with multiple sclerosis
10.1001/jama.1976.03270180041018 · doi-reference
Swine flu vaccine and multiple sclerosis
10.1001/jama.1984.03340440030022 · doi-reference
Swine influenza vaccination in patients with multiple sclerosis
10.1001/archneur.1978.00500280060012 · doi-reference
Diffuse vaculitis and death after hyperimmunization with pertussis vaccine. Report of a case
10.1056/nejm196603172741107 · doi-reference
Acute vascular purpura following immunization with asiatic influenza vaccine
10.1056/nejm195807032590102 · doi-reference
Renal disease following prophilactic inoculation
10.1159/000180146 · doi-reference
10.1097/00006454-199903000-00002
10.1097/00006454-199903000-00002 · doi-reference
Association between type 1 diabetes and Haemophilus influenzae type b vaccination: birth cohort study
10.1136/bmj.318.7192.1169 · doi-reference
The Swedish childhood diabetes study. Vaccinations and infection as risk determinants for diabetes in childhood
10.1007/bf00418272 · doi-reference
Public should be told that vaccines may have long-term adverse effects
10.1136/bmj.318.7177.193 · doi-reference
The timing of pediatric immunization and the risk of insulin-dependent diabetes mellitus
10.1097/00019048-199706070-00007 · doi-reference
Antibody reactivity to mycobacterial 65kDa heat shock protein: relevance to autoimmunity
10.1006/jaut.1995.0018 · doi-reference
BCG vaccine-induced lupus vulgaris
10.1001/archderm.1982.01650150033017 · doi-reference
Systemic lupus erythematosus following Hepatitis B vaccine
10.1159/000189357 · doi-reference
Systemic lupus erythematosus and thrombocytopenic purpura in two members of the same family following hepatitis B vaccine
10.1093/ndt/13.9.2420 · doi-reference
Systemic lupus erythematosus and vaccination against hepatitis B
10.1159/000187043 · doi-reference
Herpes viruses in multicase families with rheumatoid arthritis and systemic lupus erythematosus
10.1111/j.1749-6632.1997.tb52078.x · doi-reference
Systemic lupus erythematosus associated with acute Epstein–Barr virus infection
10.1016/s0272-6386(98)70140-4 · doi-reference
The Epstein–Barr virus and systemic lupus erythematosus
10.1172/jci119845 · doi-reference
An increased prevalence of Epstein–Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus
10.1172/jci119856 · doi-reference
Tuberculose et immunite: ou en sommes-nous?
10.1016/s0924-4204(97)85207-9 · doi-reference
Arthritis after hepatitis B vaccination
10.3109/03009749509095156 · doi-reference
Lack of association of swine flu vaccine and rheumatoid arthritis
10.1016/s0025-6196(12)65615-8 · doi-reference
Some delayed complications of inoculation
10.1136/bmj.2.5000.1029 · doi-reference
Intensive immunization of man: evaluation of possible adverse consequences
10.7326/0003-4819-63-1-44 · doi-reference
Transient appearance of rheumatoid factor in connection with profilactic vaccinations
10.1111/j.1699-0463.1962.tb04201.x · doi-reference
Can immunization trigger rheumatoid arthritis
10.1136/ard.52.12.843 · doi-reference
Joint and limb symptoms in children after immunization with measles, mumps and rubella vaccine
10.1136/bmj.304.6834.1075 · doi-reference